J Korean Assoc Maxillofac Plast Reconstr Surg.  2003 May;25(3):199-205.

Determination of pretreatment serum CEA and SCCA in patients with oral squamous cell carcinoma

Affiliations
  • 1Depart. of Oral and Maxillofacial Surgery, College of Dentistry, Kyungpook National University, Korea. skkimdaum@hanmail.net
  • 2Department of Dentistry, Ulsan University Hospital, Korea.

Abstract

The study evaluated the usefulness of tumor markers in the diagnosis of oral squamous cell carcinoma. Serum levels of two tumor markers (carcinoembryonic antigen [CEA] and squamous cell carcinoma antigen [SCCA]) were simultaneously measured by radioimmunoassay in 21 patients with oral squamous cell carcinoma and in 22 patients with oral benign diseases. The positive rates were 19.05% for CEA and 47.62% for SCCA in patients with oral squamous cell carcinoma. The sensitivity of the combination assay (52.38%) was higher than that obtained with individual markers, but specificity was low in combination assay. Serum CEA seems to be inadequate for diagnostic purpose, but serum SCCA may be useful for diagnostic purpose in patients with oral squamous cell carcinoma. A combination assay may be useful in the diagnosis of oral squamous cell carcinoma.

Keyword

Tumor marker; CEA; SCCA; Squamous cell carcinoma

MeSH Terms

Carcinoma, Squamous Cell*
Diagnosis
Humans
Radioimmunoassay
Sensitivity and Specificity
Biomarkers, Tumor
Full Text Links
  • JKAMPRS
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr